Why the study?
Cognitive impairment is common and frequently unrecognized in patients with cardiovascular disease, where it may impact self-management and treatment adherence.
Given the high prevalence of unrecognized cognitive impairment in cardiac patients, a stepwise approach is recommended to improve detection and management.
Cognitive impairment may be prevalent yet underrecognized in cardiology clinics; leaves open optimal screening and outcome impact.
Cognitive impairment is common in patients with cardiovascular disease. One in 3 patients presenting at cardiology clinics have some degree of cognitive impairment, depending on the cardiac condition, comorbidities, and age. In up to half of these cases cognitive impairment may go unrecognized; however, it may affect self-management and treatment adherence. The high prevalence of cognitive impairment in patients with cardiac disease is likely due to shared risk factors, as well as direct consequences of cardiac dysfunction on the brain. Moreover, cardiac interventions may have beneficial as well as adverse effects on cognitive functioning. In this review, we describe prevalence and risk factors for cognitive impairment in patients with several common cardiac conditions: heart failure, coronary artery disease, and aortic valve stenosis. We discuss the potential effects of guideline-based treatments on cognition and identify open questions and unmet needs. Given the high prevalence of unrecognized cognitive impairment in cardiac patients, we recommend a stepwise approach to improve detection and management of cognitive impairment.
No takes yet. Share an insight, caveat, or question.
Nieuwkerk et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: